Orlistat, sibutramine, and rimonabant modestly reduce weight. Compared with patients receiving placebo, those receiving active drug treatment were significantly more likely to achieve 5% and 10% weight loss thresholds. Each drug resulted in average placebo subtracted weight reductions of less than 5 kg.